Genmab A/S Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit

COPENHAGEN, Denmark, Nov. 17, 2011 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today that a US District Court entered final judgment in favour of GlaxoSmithKline (GSK) in a patent infringement case involving Arzerra brought against GSK by Genentech and Biogen Idec.